Literature DB >> 14968716

RUNX and cancer.

Y Ito1, M Osato, K Ito.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14968716

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


× No keyword cloud information.
  7 in total

1.  The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Abbie Lundgreen; Marianna C Stern; Lisa Hines; Roger K Wolff; Anna R Giuliano; Kathy B Baumgartner; Esther M John
Journal:  Cancer Causes Control       Date:  2013-12-12       Impact factor: 2.506

2.  Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Roger K Wolff; Bette J Caan
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

3.  Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.

Authors:  Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Bette J Caan; John D Potter; Roger K Wolff
Journal:  Carcinogenesis       Date:  2010-11-18       Impact factor: 4.944

4.  Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Roger K Wolff; Jennifer S Herrick; Bette J Caan
Journal:  Dis Colon Rectum       Date:  2012-05       Impact factor: 4.585

5.  Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.

Authors:  Martha L Slattery; Andromahi Trivellas; Andrew J Pellatt; Lila E Mullany; John R Stevens; Roger K Wolff; Jennifer S Herrick
Journal:  Oncotarget       Date:  2017-03-07

6.  LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation.

Authors:  Ying Zhou; Xintian Zhang; Jingjing Zhang; Jingyuan Fang; Zhizheng Ge; Xiaobo Li
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

7.  Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer.

Authors:  Xiaohui Chen; Yujie Deng; Yi Shi; Weifeng Zhu; Yibin Cai; Chunwei Xu; Kunshou Zhu; Xiongwei Zheng; Gang Chen; Qi Xie; Guoxing Weng
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.